BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China · Delayed Price · Currency is CNY 36.67
-2.18 (-5.61%)
At close: Aug 21, 2026
SHA:688166 Market Cap
SHA:688166 has a market cap or net worth of 15.96 billion as of August 21, 2026. Its market cap has decreased by -65.65% in one year.
Market Cap
15.96B
Enterprise Value
18.02B
Revenue
1.30B
Ranking
n/a
PE Ratio
313.87
Stock Price
36.67
ChartMarket Cap Chart
Since November 8, 2019, SHA:688166's market cap has increased from 12.55B to 15.96B, an increase of 27.17%. That is a compound annual growth rate of 3.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 15.96B | -23.05% |
| Dec 31, 2025 | 20.74B | 62.70% |
| Dec 31, 2024 | 12.75B | -13.79% |
| Dec 29, 2023 | 14.79B | 55.07% |
| Dec 30, 2022 | 9.54B | -36.65% |
| Dec 31, 2021 | 15.05B | -19.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Yili Chuanning Biotechnology | 19.89B |
| Sinocelltech Group | 17.58B |
| GemPharmatech | 14.72B |
| Acrobiosystems | 14.34B |
| Jinyu Bio-technology | 14.31B |
| Mabwell (Shanghai) Bioscience | 14.11B |
| Anhui Anke Biotechnology (Group) | 14.10B |
| HitGen | 14.08B |